[Design and synthesis of quinoxaline derivatives and their antitumor activities].
To design and synthesize novel quinoxaline derivatives as antitumor agents. Using 4-chloro-2-nitroaniline as a starting compound, followed by substitution, reductive cyclization, oxidation, and chlorination, to give the key intermediate 2,7-dichloroquinoxaline (7), which reacted with different phenolic compounds to afford quinoxaline derivatives. The structures of the target molecules were characterized by elemental analysis, 1H NMR, MS, and IR. At concentration of 1 x 10(-4) mol x L(-1), some of the derivatives showed equal antitumor activities to XK469.